Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: Initial results

European Radiology

Volumn 16, Issue 1, 2006, Pages 80-87

  Veit, Patrick ^a   Antoch, Gerald ^a   Stergar, Hrvoje ^a   Bockisch, Andreas ^a   Forsting, Michael ^a   Kuehl, Hilmar ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Metastases; Positron emission tomography computed tomography; Postinterventional surveillance; Radiofrequency ablation; Residual tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOBITRIDOL; XENETIX 300;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTESTINE SURGERY; LIVER METASTASIS; MALE; MEDICAL SPECIALIST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RADIOLOGIST; SENSITIVITY ANALYSIS;

AGED; CATHETER ABLATION; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IOHEXOL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 30844447694     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-2767-0     Document Type: Article

References (38)

1. Ballantyne GH, Quin J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252-4266 1:STN:280:ByyB1cvlsFQ%3D
2. Gayowski TJ, Iwatsuki S, Madariaga JR et al (1994) Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors Surgery 116:703-710; discussion 710-701 1:STN:280:ByqD38nksFA%3D
3. de Baere T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol 175:1619-1625
4. Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 174:323-331 1:STN:280:DC%2BD3c7itFOrtA%3D%3D
5. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452-2463 10.1002/ 1097-0142(20000601)88:11<2452::AID-CNCR5>3.0.CO;2-3
6. Nahum Goldberg S, Dupuy DE (2001) Image-guided radiofrequency tumor ablation: Challenges and opportunities - Part I. J Vasc Interv Radiol 12:1021-1032 1:STN:280:DC%2BD3MvptlCmsA%3D%3D
7. Dupuy DE, Goldberg SN (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J Vasc Interv Radiol 12:1135-1148 1:STN:280:DC%2BD3MrjvFWqtw%3D%3D
8. Curley SA (2001) Radiofrequency ablation of malignant liver tumors. Oncologist 6:14-23 10.1634/theoncologist.6-1-14
9. McGhana JP, Dodd GD III (2001) Radiofrequency ablation of the liver: current status. Am J Roentgenol 176:3-16 1:STN:280:DC%2BD3M3itlWgsA%3D%3D
10. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol 7:593-600 1:STN:280:DC%2BD3cvltVGktg%3D%3D
11. Bilchik AJ, Wood TF, Allegra DP (2001) Radiofrequency ablation of unresectable hepatic malignancies: Lessons learned. Oncologist 6:24-33 10.1634/theoncologist.6-1-24
12. Goldberg SN, Charboneau JW, Dodd GD III et al (2003) Image-guided tumor ablation: Proposal for standardization of terms and reporting criteria. Radiology 228:335-345 12893895
13. Gillams AR, Lees WR (2004) Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261-2267 10.1007/ s00330-004-2416-z
14. Langenhoff BS, Oyen WJ, Jager GJ et al (2002) Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: A prospective study. J Clin Oncol 20:4453-4458 10.1200/JCO.2002.12.134
15. Rossi S, Buscarini E, Garbagnati F et al (1998) Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 170:1015-1022
16. Dromain C, de Baere T, Elias D et al (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255-262 11930075
17. Lim HK, Choi D, Lee WJ et al (2001) Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: Evaluation with follow-up multiphase helical CT. Radiology 221:447-454 1:STN:280:DC%2BD3MnjvFCntg%3D%3D
18. Lencioni R, Cioni D, Bartolozzi C (2001) Percutaneous radiofrequency thermal ablation of liver malignancies: Techniques, indications, imaging findings, and clinical results. Abdom Imaging 26:345-360 10.1007/ s002610000194
19. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H (2003) FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 28:192-197 10.1097/ 00003072-200303000-00005
20. Donckier V, Van Laethem JL, Goldman S et al (2003) [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84:215-223 10.1002/jso.10314
21. Antoch G, Stattaus J, Nemat AT et al (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526-533 14512512
22. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: Long-term results. Eur Radiol 11:914-921 10.1007/s003300000659
23. Denys AL, De Baere T, Kuoch V et al (2003) Radio-frequency tissue ablation of the liver: In vivo and ex vivo experiments with four different systems. Eur Radiol 13:2346-2352 10.1007/s00330-003-1970-0
24. Beyer T, Townsend DW, Blodgett TM (2002) Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med 46:24-34 1:STN:280:DC%2BD38zjtVSisA%3D%3D
25. Antoch G, Freudenberg LS, Stattaus J et al (2002) Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials. Am J Roentgenol 179:1555-1560
26. Antoch G, Kuehl H, Kanja J et al (2004) Dual-Modality PET/CT Scanning with negative oral contrast agent to avoid artifacts: Introduction and evaluation. Radiology 230:879-885 14764889
27. Beyer T, Antoch G, Blodgett T, Freudenberg LF, Akhurst T, Mueller S (2003) Dual-modality PET/CT imaging: The effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 30:588-596 12582813
28. Kinahan PE, Townsend DW, Beyer T, Sashin D (1998) Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25:2046-2053 10.1118/1.598392
29. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133:510-515; discussion 515-516 10.1001/ archsurg.133.5.510
30. Beggs AD, Hain SF, Curran KM, O'Doherty MJ (2002) FDG-PET as a "metabolic biopsy" tool in non-lung lesions with indeterminate biopsy. Eur J Nucl Med Mol Imaging 29:542-546 10.1007/s00259-001-0736-7
31. Patz EF Jr, Lowe VJ, Hoffman JM et al (1993) Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188:487-490 8327702
32. Limanond P, Zimmerman P, Raman SS, Kadell BM, Lu DS (2003) Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. Am J Roentgenol 181:1635-1640
33. Fong Y, Saldinger PF, Akhurst T et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178:282-287 10.1016/ S0002-9610(99)00187-7
34. Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF (2004) To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 45(Suppl 1):56S-65S 1:CAS:528:DC%2BD2cXht1arur8%3D
35. Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 44:1200-1209 12902408
36. Antoch G, Vogt FM, Freudenberg LS et al (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199-3206 10.1001/jama.290.24.3199
37. Antoch G, Kuehl H, Vogt FM, Debatin JF, Stattaus J (2002) Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. J Vasc Interv Radiol 13:1155-1161 12427816
38. Verdun RF, Noel A, Meuli R et al (2004) Influence of detector collimation on SNR in four different MDCT scanners using a reconstructed slice thickness of 5 mm. Eur Radiol 14:1672-1866